ArticleThe Journal of infectious diseases2023

Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.

Carlee B Moser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.